SUMMARY
T-bet is a critical transcription factor for T helper 1 (Th1) cell differentiation. To study the regulation and functions of T-bet, we developed a T-betZsGreen reporter mouse strain. We determined that interleukin-12 (IL-12) and interferon-g (IFN-g) were redundant in inducing T-bet in mice infected with Toxoplasma gondii and that T-bet did not contribute to its own expression when induced by IL-12 and IFN-g. By contrast, T-bet and the transcription factor Stat4 were critical for IFN-g production whereas IFN-g signaling was dispensable for inducing IFN-g. Loss of T-bet resulted in activation of an endogenous program driving Th2 cell differentiation in cells expressing T-bet-ZsGreen. Genome-wide analyses indicated that T-bet directly induced many Th1 cellrelated genes but indirectly suppressed Th2 cellrelated genes. Our study revealed redundancy and synergy among several Th1 cell-inducing pathways in regulating the expression of T-bet and IFN-g, and a critical role of T-bet in suppressing an endogenous Th2 cell-associated program.
INTRODUCTION

CD4
+ T helper (Th) cells play critical roles in orchestrating adaptive immune responses to pathogens, mainly through cytokine production (Murphy and Reiner, 2002; . They are also involved in pathological responses to self-antigens and to nonharmful allergens, resulting in autoimmune and allergic diseases, respectively. Activated CD4 + T cells are classified on the basis of their capacity to produce unique cytokines, their distinct homing properties, and their particular functions during various immune responses. They develop from naive CD4 + T cells when antigen-specific T cell receptors (TCRs) as well as cytokine receptors on these cells are activated.
In vitro, interleukin-12 (IL-12)-and interferon (IFN)-g-mediated signaling, through the activation of the transcription factors Stat4 and Stat1, respectively, together with TCR activation, are important for T helper type 1 (Th1) cell differentiation. IL-2 and IL-4 are critical for T helper type 2 (Th2) cell differentiation (Ansel et al., 2006; Oestreich and Weinmann, 2012; .
T-bet is a critical transcription factor of Th1 cells. It plays an important role in regulating IFN-g production (Szabo et al., 2000; Szabo et al., 2002) . Naive CD4 + T cells do not express T-bet. IFN-g has been shown to induce T-bet expression, which results in a potential positive feedback loop during Th1 cell differentiation (Afkarian et al., 2002; Lighvani et al., 2001) . IL-12 also induces T-bet in an IFN-g-Stat1-independent manner in CD8 + T cells (Yang et al., 2007) . The relative importance of IL-12 and IFN-g in T-bet induction as well as IFN-g expression especially during in vivo Th1 cell responses has not been established. Furthermore, retroviral T-bet has been reported to induce endogenous T-bet expression (Mullen et al., 2001) ; however, whether endogenous T-bet directly regulates its own expression or does so indirectly through its upregulation of IFN-g and/or IL-12Rb2 is still unclear. Similarly, the mechanism of Th2 cell differentiation in vivo has been an enigma since the earliest demonstration of the Th2 cell differentiation process. IL-4 plays an essential role for Th2 cell differentiation in vitro. Assuming a comparable role for IL-4 in vivo, the source of such IL-4 remains controversial, particularly given that professional antigen-presenting cells (APCs), such as dendritic cells, do not produce IL-4. Recently, it has been proposed that basophils serve as Th2 cell-promoting APCs and that they produce IL-4 and/or thymic stromal lymphpoietin (TSLP) for such a purpose (Perrigoue et al., 2009; Sokol et al., 2008; Sokol et al., 2009; Yoshimoto et al., 2009 ). However, the role of basophils in antigen presentation remains controversial (Kim et al., 2010) . Furthermore, Th2 cell differentiation in several, but not all, parasite infection models occurs in IL-4-, IL-4Ra-or Stat6-deficient mice, indicating that IL-4-mediated signaling is not essential for initiating Th2 cell differentiation in vivo (Finkelman et al., 2000; Jankovic et al., 2000; Min et al., 2004; Voehringer et al., 2004) . It has been proposed that Th2 cell differentiation may occur through a default pathway; however, CD4 + T cells in IL-12-deficient mice fail to default to Th2 cells in response to intracellular pathogens (Jankovic et al., 2002) .
GATA3 is the critical transcription factor for Th2 cell differentiation both in vitro and in vivo (Pai et al., 2004; Zhang et al., 1997; Zheng and Flavell, 1997; Zhu et al., 2004) . GATA3 is also indispensable for CD4 + T cell development in the thymus at multiple stages and thus, unlike T-bet, which is not expressed in naive CD4 + T cells, GATA3 is detected in naive CD4 + T cells (Ho et al., 2009 ). IL-4-mediated Stat6 activation is the main inducing signal for GATA3 upregulation in vitro. T cell receptor activation, particularly with low-dose antigen, also upregulates GATA3 expression (Yamane et al., 2005) . On the other hand, GATA3 is downregulated during Th1 cell differentiation. Th2 cells may develop with low amounts of GATA3 expression but even in such cases, GATA3 is essential (Zhu et al., 2003) To study the CD4 + T cell differentiation process and crossregulation both in vitro and in vivo, we developed a T-bet reporter mouse strain. Using this research tool, we observed that IL-12 and IFN-g were redundant in inducing T-bet during in vitro culture and in vivo immune responses to T. gondii. IFN-g signaling was dispensable for generating IFN-g-producing T cells under the conditions tested. Furthermore, T-bet collaborated with Stat4 in inducing IFN-g production but was not required for its own expression in the presence of IL-12 and IFN-g. When T-bet was absent, T. gondii infection elicited expression of the T-bet reporter while inducing a Th2 cell differentiation program, including IL-4 production and GATA3 upregulation, in the same cells. Our result suggests that an endogenous program for in vivo Th2 cell differentiation exists and that it is normally repressed by T-bet during Th1 cell differentiation. In the absence of T-bet, this program can be activated in the absence of Th2 cell-stimulating cytokines.
RESULTS
T-bet-ZsGreen Reporter Faithfully Reflects the Expression of Endogenous T-bet
To study the regulation of T-bet expression and the functions of T-bet-expressing cells both in vitro and in vivo, we generated a bacterial artificial chromosome (BAC) transgenic T-bet reporter mouse strain. The coding region of ZsGreen (ZsG), an improved version of green fluorescent protein (GFP), was inserted into the T-bet translational start site in the BAC clone RP23-237M14. From such design, ZsG but not T-bet protein will be expressed from the transgenic BAC; T-bet will continue to be expressed from the endogenous Tbx21 gene. The reporter strain was designated the T-bet green reporter (TBGR).
ZsG expression was detected in subsets of splenocytes and lymph node cells from unimmunized TBGR mice ( Figure 1A and Figure S1 available Figure 1D ). These results confirm that the ZsG reporter faithfully reflects T-bet-expressing Th1 cells.
IL-12 and IFN-g Are Redundant in Inducing T-bet Expression Both IL-12 and IFN-g have been reported to upregulate T-bet expression (Oestreich and Weinmann, 2012) ; however, their relative contribution in inducing T-bet is unknown. Using CD4 + T cells from TBGR mice, we studied T-bet induction by IL-12 and IFN-g in cells stimulated with anti-CD3 and anti-CD28. When IL-12 and IFN-g were both neutralized during in vitro priming, no ZsG induction was detected, whereas virtually all the TBGR CD4 + T cells were ZsG + when both IL-12 and IFN-g were added to the culture ( Figure 2A ). Addition of either IL-12 or IFN-g alone, while neutralizing the alternative cytokine, induced ZsG expression in the majority of the cells, although the mean fluorescence intensity (MFI) was somewhat lower.
To rule out the possibility that IL-12 or IFN-g had been incompletely neutralized, we examined TBGR mice that were singly (Ifngr1 À/À or Stat4 To study T-bet induction by IL-12 and IFN-g in vivo, we infected TBGR mice with T. gondii, a pathogen that elicits strong Th1 cell responses (Jankovic et al., 2007) , and assessed T-bet and IFN-g expression 1 week after infection. Similar to the findings obtained in vitro, deficiency in either IFN-gR1 or Stat4 resulted in a modest reduction in ZsG expression, both in percentage of positive cells and in MFI of ZsG in these cells (Figure 2C) . By contrast, some CD4 + T cells from Ifngr1
TBGR mice upregulated T-bet, although the proportion that did so was less than that of singly deficient cells ( Figure 2D ). These results indicate that under in vivo conditions, T-bet can be induced in an IL-12-and IFN-g-independent manner and that such inducing signal(s) are absent in our in vitro Th1 cell-polarizing conditions. Addition of type I IFNs or IL-27 to the culture of in vitro-differentiating Ifngr1 Figure S2 ), suggesting these cytokines may be responsible for IL-12-and IFN-g-independent T-bet induction in vivo. In contrast to requirements for in vivo T-bet induction, Stat4 deficiency dramatically diminished the capacity of these cells to produce IFN-g ( Figure 2E ). Deficiency in IFN-gR1 had a very small effect on IFN-g production, despite reduced T-bet expression consistent with a previous report that Stat1 is not required for the development of IFN-g-producing CD4 + T cells (Lieberman et al., 2004) . Given that Stat4 À/À TBGR cells expressed similar amounts of ZsG as Ifngr1 À/À TBGR cells did ( Figure 2C ), the differential IFN-g production by these cells implies that Stat4 has an effect on IFN-g production in addition to its role in inducing T-bet and that T-bet without STAT4 does not induce optimal IFN-g production.
T-bet and Stat4 Synergize in Inducing IFN-g Production T-bet is regarded as a critical regulator of Th1 cells and directly regulates IFN-g production by binding to several conserved sites at the Ifng locus (Hatton et al., 2006) . However, Stat4 also appears to directly regulate IFN-g production as shown by the dramatic reduction of IFN-g production with only a modest decrease of ZsG expression in Stat4 À/À TBGR mice.
To investigate the relative importance of T-bet and Stat4 in regulating T-bet and IFN-g production, we generated T-bet singly deficient (Tbx21 Figure 2C ). These results imply that T-bet may participate in its own expression in instances in which the third, yet unknown, signaling pathway is responsible for T-bet expression. Nonetheless, T-bet or Stat4 deficiency alone caused substantial reduction in the frequency of IFN-g-producing cells and the combination of T-bet and Stat4 deficiency completely abolished IFN-g production ( Figure 3C ).
T-bet Suppresses IL-4 and GATA3 Expression during T. gondii Infection T-bet has been reported to suppress Th2 cell differentiation when it is overexpressed (Szabo et al., 2000; Usui et al., 2006) . When Tbx21 À/À mice are infected with Leishmania major, IFN-g production is dramatically reduced while IL-4 production is induced (Szabo et al., 2002) . Given that L. major elicits Th1 cell responses in C57BL/6 mice and Th2 cell responses in BALB/c mice, it is likely that, in the absence of T-bet, the environment for CD4 + T cell differentiation may have been switched from favoring Th1 to favoring Th2 cell differentiation. On the other hand, T. gondii infection elicits strong Th1 cell responses both in C57BL/6 and BALB/c mice. The WT and Tbx21 À/À TBGR mice allow us to examine the role of T-bet in inducing Th1 and suppressing Th2 cell Figure 4B ). Gata3 mRNA was also induced in the absence of T-bet, suggesting the signals involved in upregulating T-bet expression are not sufficient to directly suppress GATA3 in the absence of T-bet. Intracellular staining for GATA3 confirmed that GATA3 expression was much higher in Figure 5A ). In contrast, among cells from the Tbx21 À/À donors, 15%-20% of both the ZsG + and ZsG neg cells produced IL-4 but only 2%-3% produced IFN-g.
This result indicates that T-bet plays a critical cell-intrinsic positive role in Th1 cell differentiation and negative role in Th2 cell differentiation in homeostatic proliferation just as it does in T. gondii infection. IL-4 plays a major role in Th2 cell differentiation in vitro. However, many in vivo Th2 cell-associated responses are either independent of the IL-4-Stat6 pathway or only partially dependent upon it. T-bet deficiency leads to upregulation of Th2 cell signature genes even in the cells expressing the T-bet reporter, suggesting that in the absence of T-bet, Th2 cell differentiation proceeds without ''conventional'' exogenous Th2 cell inducing stimuli. Indeed, culturing naive Tbx21 À/À TBGR CD4 + T cells in vitro under ''Th1'' cell differentiation conditions (i.e., anti-CD3, anti-CD28, IL-12, and anti-IL-4), although it led to virtually all the responding cells being ZsG + , resulted in a substantial percentage of these cells being able to produce IL-4 in response to phorbol myristate acetate (PMA) and ionomycin ( Figure 5B ). Thus, under classical Th1 cell-polarizing conditions, in which IL-4 is neutralized, the absence of T-bet allows Th2 cell differentiation to go forward in at least a portion of the cells under study.
T-bet and GATA3 Cross-regulation Affects Many Th1 and Th2 Cell-Specific Genes To further explore the mechanisms of T-bet-mediated gene regulation, we performed a T-bet ChIPseq to map T-bet binding sites genome-wide in WT Th1 cells. Modification-specific histone ChIPseq as well as RNaseq were carried out with WT and Tbx21 À/À TBGR + Th1 cells so that genes regulated by T-bet could be identified. RNaseq results showed that 219 and 211 genes were positively or negatively regulated by T-bet, respectively, with >2-fold change between WT and Tbx21 À/À cells ( Figure 6A , upper panels). ChIPseq results indicated that T-bet bound to 2493 genes in Th1 cells; in the absence of T-bet, H3K4me1 and H3H27me3 modification peaks within 4173 and 2875 genes, respectively, were reduced (at least one peak per gene). Overall, only $4% and $2% of the T-bet bound genes were positively and negatively regulated by T-bet at a transcriptional level, respectively ( Figure 6A , lower left). Among the 1183 genes that were bound by T-bet and displayed reduced H3K4me1 modification in the absence of T-bet, the percentage of the genes that were positively regulated by T-bet was increased to $7%, whereas, the percentage of the genes that were negatively regulated by T-bet remained $2%. On the other hand, among the 663 genes that were bound by T-bet and displayed reduced H3K27me3 modification in the absence of T-bet, the percentage of the genes that were negatively regulated by T-bet was enriched to $4%, whereas the percentage of the genes that are positively regulated by T-bet remained the same as that of the total T-bet-bound genes. In the absence of T-bet, 47% and 27% of the total 2493 T-bet-bound genes displayed reduced H3K4me1 and H3K27me3, respectively ( Figure 6A , lower right). Higher percentages of T-bet-bound genes were regulated by T-bet in histones modifications than in gene expression suggesting T-bet may regulate gene expression at an epigenetic level. Among the 97 genes that were bound and positively regulated by T-bet, 82% had reduced H3K4me1 modification in the absence of T-bet, whereas among the 45 genes that were bound and negatively regulated by T-bet, 58% displayed reduced H3K27me3 in the absence of T-bet. Therefore, T-bet may promote H3K4me1 or H3K27me3 modifications through which it positively or negatively regulates gene expression. 
Immunity T-bet Prevents an Endogenous Th2 Cell Program
T-bet bound to the Ifng, Il12rb2, and Cxcr3 loci and promoted H3K4me1 modification around the binding sites of the genes (Figures 6B-6D) . At the Ifng locus, T-bet bound to many sites including CNS-6 (6 kb upstream of transcription start site) at which H3K4me1 modification was dramatically reduced in the absence of T-bet ( Figure 6B) . Similarly, T-bet bound to an intron 
of the Il12rb2 and the 5 0 enhancer of the Cxcr3; without T-bet, H3K4me1 modification was reduced around these binding sites ( Figures 6C and 6D) . On the other hand, T-bet directly sup- pressed the expression of CCR6, a Th17 cellspecific chemokine receptor; T-bet bound to an intron of the Ccr6 gene and promoted H3K27me3 around this binding site. Previously, T-bet has been reported to suppress Runx1-mediated RORgt upregulation (Lazarevic et al., 2011 ). Although we did not detect increased expression of RORgt in T-betdeficient ''Th1'' cells, our data indicate T-bet also binds to the Rorc gene and promotes H3K27me3 around its binding site ( Figure S3 ). Because we noticed that T-bet deficient ''Th1'' cells produce IL-4, which is a signature Th2 cell cytokine, we analyzed gene regulation of Th1 and Th2 cell-specific genes by T-bet at a genome-wide level. We have previously identified $90 Th1 and Th2 cell-specific genes (Wei et al., 2011) . Approximately 50% of the Th1 cell-specific genes were positively regulated by T-bet ( Figure 7A ). Interestingly, 26 out of 90 Th2-specific genes were negatively regulated by T-bet. Genes positively regulated by T-bet included many well-known Th1 cellspecific genes such as Cxcr3, Ifng, Nkg7, Fasl, Il12rb2, Txk, Il18r1 , and Lta ( Figure 7B , left side). Genes that were negatively regulated by T-bet included dozens of Th2 cell-specific genes such as Ecm1, Pparg, Ccr4, Fos, Il5, Il4, Ccr1 , and Il13 ( Figure 7B, right side) . Interestingly, T-bet bound to all these Th1 cell-specific genes but only one of the negatively regulated Th2 cell-specific genes. Indeed, we have reported that all these Th2 cell-specific genes as well as some of these Th1 cell-specific genes are bound by GATA3 in Th2 cells (Wei et al., 2011) . At the genome level, T-bet bound to and positively regulated $60% of the 44 Th1 cell-specific genes. Although T-bet bound to and negatively regulated only $20% of the 26 Th2 cell-specific Immunity T-bet Prevents an Endogenous Th2 Cell Program genes, GATA3 bound to $70% of these genes. Thus, it is likely that the upregulation of these Th2 cell-specific genes in the Tbx21 À/À ''Th1'' cells is due to the enhanced GATA3 function as well as expression that occurs in the absence of T-bet. Indeed, T-bet strongly bound to at least two sites around the Gata3 locus ( Figure 7D, upper panel) . In keeping with a modest upregulation of GATA3 expression in T-bet-deficient Th1 cells ($1.7-fold increase), histone H3 tri-methylation at position K27 (H3K27me3), a suppressive histone mark, found in the immediate vicinity of these two T-bet binding sites at the Gata3 locus, was substantially reduced in T-bet-deficient Th1 cells when compared to that of WT Th1 cells ( Figure 7D, lower panel) . Therefore, T-bet may directly inhibit GATA3 expression in Th1 cells possibly by promoting H3K27me3 modification at the Gata3 locus in addition to the ability of T-bet in inhibiting GATA3 function through protein-protein interaction as previously reported (Hwang et al., 2005) . Thus, the balance between T-bet and GATA3 during T cell differentiation plays a critical role in determining the expression of Th1 and Th2 lineage-specific genes and without T-bet induction, GATA3 drives Th2 cell differentiation in the absence of IL-4.
DISCUSSION
We prepared the TBGR indicator mouse strain allowing us to study Th1 cell differentiation both in vitro and in vivo. We showed that ZsG expression faithfully reflects endogenous T-bet expression. Using this T-bet reporter system, we could study the regulation of T-bet at a single-cell level with a greater sensitivity both in vitro and in vivo than was previously possible. Either IL-12 or IFN-g alone was sufficient to induce T-bet 
thus, it is possible that these cytokines are responsible for IL-12-and IFN-g-independent induction of T-bet in vivo. Further investigation is required to confirm such regulation. We also found that T-bet was not required for its own induction when IL-12 or IFN-g are present given that ZsG is expressed at the same amounts in both WT and Tbx21 À/À TBGR cells in response to T. gondii infection or when cultured in vitro under Th1 cell-polarizing conditions. Nonetheless, T-bet may be involved in directly promoting its own expression when induced by the ''IL-12-and IFN-g-independent'' pathway, given that the ZsG expression is much lower in Stat4
Consistent with a redundant role of IFN-g and IL-12 in inducing T-bet, cells that fail to respond to IFN-g, specifically Ifngr1
À/À cells, were still able to produce IFN-g at a level comparable to that found in WT cells, especially in vivo. These results suggest the positive feedback loop mediated by IFN-g makes only a limited contribution to full Th1 cell differentiation under the suggesting that Stat4 is critical for collaborating with T-bet in inducing IFN-g production as previously reported in an in vitro culture system (Thieu et al., 2008) . Indeed, Stat4 directly binds to the Ifng locus . The importance of Stat4 is particularly evident when no exogenous IFN-g was provided; Stat4 À/À cells produced less IFN-g and, therefore, such cells not only had an IL-12 signaling defect but also received less IFN-g stimulation. Either Stat4 or T-bet was able to induce some IFN-g production but together they could collaborate to induce maximal IFN-g production; no IFN-g production could be detected in Stat4 À/À Tbx21 À/À cells either in vitro or in vivo.
Thus, these two factors both play critical roles in inducing IFN-g during Th1 cell responses and Stat4 is responsible for T-bet-independent IFN-g production. It is common that during a particular type of Th cell differentiation, the specific program involved also actively inhibits the capability of the differentiating cells to become cells of other Th cell phenotypes . Transcription factors induced in each lineage, particularly the critical regulators, are often involved in such cross-regulation. For example, GATA3 not only represses Stat4 expression (Usui et al., 2003) , but also suppresses Runx3-mediated IFN-g induction (Yagi et al., 2010) and modifies the Tbx21 locus during Th2 cell differentiation (Wei et al., 2011) . On the other hand, when overexpressed, T-bet suppresses GATA3 expression at the transcriptional level (Usui et al., 2006) . T-bet also suppresses GATA3 function through protein-protein interaction (Hwang et al., 2005) . T-bet and GATA3 share many target genes when coexpressed (Jenner et al., 2009 ). Here, we have shown that endogenous T-bet is critical for inhibiting GATA3 function during both in vitro and in vivo Th1 cell differentiation, preventing these ''Th1-differentiating'' cells from activating a ''default'' Th2 cell differentiation program, a program that they do activate when T-bet is absent.
Although cultured Th2 cells express the highest amounts of GATA3 among Th cells, all CD4 + T cells, including naive cells, express GATA3 (Wei et al., 2011) . The expression of GATA3 is upregulated during Th2 cell differentiation and downregulated during Th1 and Th17 cell differentiation in vitro. However, under certain circumstances, Th2 cell differentiation may occur with low amounts of GATA3 expression, although such GATA3 continues to be essential (Zhu et al., 2003) . Stat5 activation is a second critical element for IL-4 production and thus Th2 cell differentiation (Cote-Sierra et al., 2004; Zhu et al., 2003) . Stat5 is the key signaling molecule for most members of the gc family cytokines, including IL-2 and IL-7 (Rochman et al., 2009) .
Unlike GATA3, the other two key transcription factors, T-bet and RORgt, are not expressed by naive CD4 + T cells. Similarly, Stat4 and Stat3 activation are usually triggered by cytokines, such as IL-12 and IL-6, produced by APCs, whereas Stat5 can be activated by IL-2 that is produced by CD4 + T cells upon activation. Therefore, basal expression of GATA3 as well as continuous autocrine activation of Stat5 in naive and freshly activated CD4 + T cells provide an internal Th2 cell differentiating setting and thus lead to Th2 cell differentiation without an exogenous source of cytokines. Thus, it could be argued that unless specifically prevented, Th2 cell differentiation is likely to occur without a requirement for specific inducing cytokines produced by APCs or other accessory cells. Over the years, immunologists have struggled to determine how Th2 cell-associated responses are initiated physiologically . APCs can produce IL-12 that drives Th1 cell differentiation or TGFb or IL-6 that induce Th17 cell differentiation. However, IL-4 is not produced by conventional APCs. 2009; Yoshimoto et al., 2009 ). However, IL-4 is not always essential for Th2 cell-associated responses in vivo so that these capabilities of basophils, even if they are confirmed as potent APCs, may not prove to be essential for the Th2 cell bias they have been reported to exert. Indeed, basophils are not required for Th2 cell differentiation in response to Nippostrongylus brasiliensis infection (Kim et al., 2010) . Low-dose antigen stimulation or weak antigen presentation have been proposed as another model of Th2 cell differentiation (Steinfelder et al., 2009; Yamane et al., 2005) ; the Schistosoma mansoni egg product omega-1 has been reported to diminish dendritic cell function, presumably creating a low TCR signal strength environment. Nonetheless, there is as yet no convincing data showing that either mechanism is essential for Th2 cell induction. Our report here clearly shows that even under a strong Th1 cellbiasing stimulation either in vitro or in vivo, evident by the induction of T-bet reporter, in the absence of T-bet, such cells become Th2-like cells. The failure of CD4 + T cells in IL-12-deficient mice to default to a Th2 cell program in a Th1 cellinducing environment may be explained by induction of T-bet induction by signals other than IL-12.
In conclusion, by using a T-bet reporter mouse strain crossbred to various gene-deficient mouse strains, we have carefully dissected the network of multiple cytokine pathways elicited by IL-12 and IFN-g, and the role of Stat4 and T-bet in the induction of Th1 and Th2 cell signature molecules during in vivo Th1 responses. Our results also strongly indicate that Th2 cell differentiation may occur without CD4 + T cells receiving differentiation-biasing signals from APCs, consistent with this being a ''default'' pathway.
EXPERIMENTAL PROCEDURES
Mice and Cell Culture Tbx21 À/À mice (line 4648) and Ifngr1 À/À (line 3288) were obtained from Jackson laboratory (Szabo et al., 2002) . Stat4 À/À mice have been previously described (Kaplan et al., 1996) and they have been backcrossed to C57BL/6 background. C57BL/6 Tcra À/À (line 98) mice were obtained from Taconic.
The C57BL/6 T-bet-ZsGreen reporter (TBGR) mouse strain was generated as described in Supplemental Experimental Procedures. In brief, the coding region of ZsGreen was inserted into the ATG translational starting site of a genomic fragment encoding T-bet in the BAC clone (RP23-237M14) by recombineering technology with the galK replacement method so that T-bet expression from the BAC was replaced by GFP expression. The modified BAC clone, after sequence verification of manipulated region, was used for generating transgenic mice by pronuclear microinjection of fertilized C57BL/6 eggs. The offspring of the founder (B6-Tbet-ZsGreen-E3) that carried only one copy of the transgene were selectively maintained and bred to various mouse strains deficient in different genes. The TBGR mice were genotyped with the following primers: ZsGreen (F), 5 0 -AAG GGC GAC GTG AGC ATG T-3 0 and ZsGreen (R), 5 0 -CAC GGA CTT GGC CTT GTA CAC-3 0 . All the mice were bred and maintained in the NIAID-specific pathogen free animal facility and the experiments were done when mice were at 8-16 weeks of age under protocols approved by the NIAID Animal Care and Use Committee. by incubation with anti-Thy1.2 mAb supernatant and rabbit complement (Cedarlane Laboratories Limited) at 37 C for 45 min followed by irradiation at 30 Gy (3,000 rad). Naive CD4 + T cells were cultured with irradiated T cell-depleted splenocytes at a ratio of 1:5 in the presence of 1 mg/ml of anti-CD3 (145-2C11) and 3 mg/ml of anti-CD28 (37.51) for 3-4 days with various combinations of antibodies and cytokines: For Th1 cell conditions, 10 IU/ml of hIL-2, 10 ng/ml of IL-12, and 10 mg/ml anti-IL-4 (11B11) (some Th1 cell cultures include 10 ng/ml IFN-g as specified); for Th2 cell conditions, 50 IU/ml of hIL-2, 5000 U/ml of IL-4, 10 mg/ml anti-IL-12 (C17.8), and anti-IFN-g (XMG1.2); for Th17 cell conditions, 1 ng/ml TGFb, 10 ng/ml IL-6, 10 ng/ml IL-1b, 10 mg/ml anti-IL-4, 10 mg/ml anti-IL-12, and anti-IFN-g. The activated cells were then cultured in RPMI-1640 medium with 10% FBS that contains IL-2 (50 U/ml for Th1 and 100 U/ml for Th2) or cytokine-free medium for Th17 cells.
Cell Preparation and Activation
Toxoplasma gondii Infection T. gondii cysts (the avirulent strain ME-49) were prepared from the brains of infected C57BL/6 mice. Mice were inoculated i.p. with an average of 20 cysts per animal and splenocytes were analyzed 1 week after infection.
Flow Cytometric Analysis
Cell surface molecules such as CD4, CD8, CD44, CD25, and CD62L were stained in PBS with 0.5% BSA. Cytokine intracellular staining was performed as previously described . In brief, the activated cells were restimulated with10 ng/ml phorbol 12-myristate 13-acetate (PMA) and 500 nM ionomycin in the presence of 2 mM monensin for 4 hr. Splenocytes harvested from T. gondii-infected mice were harvested and stimulated with plate-bound anti-CD3/anti-CD28 (3 ug/ml of each used for coating) for 4 hr in the presence of monension. At the end of stimulation, cells were washed and fixed with 4% paraformaldehyde for 10 min at room temperature and permeabilized in PBS containing 0.5% Triton X-100 and 0.1% BSA. They were then stained for cytokines together with CD4 and CD44. Data were collected with LSR II (BD Biosciences) and results were analyzed with FlowJo software (Tree Star). All the antibodies for staining cell surface markers or cytokines were purchased from either BD Biosciences or eBiosciences. Staining of the transcription factors were carried out with Foxp3 Staining Buffer Set (eBioscience) in accordance with the manufacturer's instructions. Anti-GATA3 (L50-823), anti-Foxp3 (FJK-16s) and anti-T-bet (4B10) were purchased from BD Biosciences and e-Biosciences, respectively.
RNA Purification and Quantitative PCR
Total RNAs were isolated with a combination of TRIzol (Invitrogen) and RNeasy Kit (QIAGEN). cDNAs were prepared with SuperScript III Reverse Transcriptase (Invitrogen). Quantitative PCR was performed on a 7900HT Sequence Detection System (Applied Biosystems) with the following predesigned primer and probe sets: Il4, Ifng, Tbx21, Cd4 (all purchased from Applied Biosystems), and Gata3 as previously described .
ChIP-Seq and RNA-Seq ChIP-Seq experiments were performed as previously described (Barski et al., 2007) . In brief, chromatin was prepared by sonication from the cells crosslinked with 1% formaldehyde for 10 min and immunoprecipitated with the anti-T-bet antibody (sc-21749, Santa Cruz). For histone ChIPseq, cells were treated with MNase to generate $80% mononucleosomes and 20% dinucleosomes. Antibodies against histone H3K4me1 (ab8895, Abcam) and H3K27me3 (07-449, Upstate) were used. The ChIP DNA was blunt-ended, ligated to the Solexa adaptors, amplified, and sequenced with an Illumina HiSeq system. Detailed data analyses are described in Supplemental Experimental Procedures.
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